These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9815960)

  • 21. A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity.
    Weldon JE; Xiang L; Chertov O; Margulies I; Kreitman RJ; FitzGerald DJ; Pastan I
    Blood; 2009 Apr; 113(16):3792-800. PubMed ID: 18988862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of vascular leak syndrome induced by the toxin component of Pseudomonas exotoxin-based immunotoxins and its potential inhibition with nonsteroidal anti-inflammatory drugs.
    Siegall CB; Liggitt D; Chace D; Mixan B; Sugai J; Davidson T; Steinitz M
    Clin Cancer Res; 1997 Mar; 3(3):339-45. PubMed ID: 9815690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice.
    Reiter Y; Wright AF; Tonge DW; Pastan I
    Int J Cancer; 1996 Jul; 67(1):113-23. PubMed ID: 8690511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv.
    Reiter Y; Brinkmann U; Webber KO; Jung SH; Lee B; Pastan I
    Protein Eng; 1994 May; 7(5):697-704. PubMed ID: 8073039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A recombinant immunotoxin containing a disulfide-stabilized Fv fragment.
    Brinkmann U; Reiter Y; Jung SH; Lee B; Pastan I
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7538-42. PubMed ID: 8356052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of RFB4-Pseudomonas exotoxin A immunotoxins targeted to CD22 on B-cell malignancies.
    Mansfield E; Pastan I; FitzGerald DJ
    Bioconjug Chem; 1996; 7(5):557-63. PubMed ID: 8889017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo cytotoxic activities of recombinant immunotoxin 8H9(Fv)-PE38 against breast cancer, osteosarcoma, and neuroblastoma.
    Onda M; Wang QC; Guo HF; Cheung NK; Pastan I
    Cancer Res; 2004 Feb; 64(4):1419-24. PubMed ID: 14973056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An immunotoxin with increased activity and homogeneity produced by reducing the number of lysine residues in recombinant Pseudomonas exotoxin.
    Debinski W; Pastan I
    Bioconjug Chem; 1994; 5(1):40-6. PubMed ID: 8199233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patients.
    Onda M; Nagata S; FitzGerald DJ; Beers R; Fisher RJ; Vincent JJ; Lee B; Nakamura M; Hwang J; Kreitman RJ; Hassan R; Pastan I
    J Immunol; 2006 Dec; 177(12):8822-34. PubMed ID: 17142785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monovalent immunotoxin containing truncated form of Pseudomonas exotoxin as potent antitumor agent.
    Debinski W; Pastan I
    Cancer Res; 1992 Oct; 52(19):5379-85. PubMed ID: 1394141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotoxins recognising a new epitope on the neural cell adhesion molecule have potent cytotoxic effects against small cell lung cancer.
    Zangemeister-Wittke U; Collinson AR; Frösch B; Waibel R; Schenker T; Stahel RA
    Br J Cancer; 1994 Jan; 69(1):32-9. PubMed ID: 7506925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression cloning of cDNAs that render cancer cells resistant to Pseudomonas and diphtheria toxin and immunotoxins.
    Brinkmann U; Brinkmann E; Pastan I
    Mol Med; 1995 Jan; 1(2):206-16. PubMed ID: 8529099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Independent domain folding of Pseudomonas exotoxin and single-chain immunotoxins: influence of interdomain connections.
    Brinkmann U; Buchner J; Pastan I
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3075-9. PubMed ID: 1557415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma.
    Kreitman RJ; Bailon P; Chaudhary VK; FitzGerald DJ; Pastan I
    Blood; 1994 Jan; 83(2):426-34. PubMed ID: 8286741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential.
    Yu Y; Li J; Zhu X; Tang X; Bao Y; Sun X; Huang Y; Tian F; Liu X; Yang L
    Int J Nanomedicine; 2017; 12():1969-1983. PubMed ID: 28331319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression, purification, and characterization of an immunotoxin containing a humanized anti-CD25 single-chain fragment variable antibody fused to a modified truncated Pseudomonas exotoxin A.
    Wang H; Dai J; Li B; Fan K; Peng L; Zhang D; Cao Z; Qian W; Wang H; Zhao J; Guo Y
    Protein Expr Purif; 2008 Mar; 58(1):140-7. PubMed ID: 17950620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted therapy of carcinomas using BR96 sFv-PE40, a single-chain immunotoxin that binds to the Le(y) antigen.
    Siegall CB
    Semin Cancer Biol; 1995 Oct; 6(5):289-95. PubMed ID: 8562906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Tac(Fab)-PE40, a recombinant double-chain immunotoxin which kills interleukin-2-receptor-bearing cells and induces complete remission in an in vivo tumor model.
    Kreitman RJ; Chang CN; Hudson DV; Queen C; Bailon P; Pastan I
    Int J Cancer; 1994 Jun; 57(6):856-64. PubMed ID: 8206679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia.
    Kreitman RJ; Chaudhary VK; Waldmann T; Willingham MC; FitzGerald DJ; Pastan I
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8291-5. PubMed ID: 2236041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin.
    Batra JK; Kasprzyk PG; Bird RE; Pastan I; King CR
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5867-71. PubMed ID: 1352878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.